Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Boehringer Ingelheim & Enleofen Ink $1 Billion+Fibrosis Deal

View:

Post by StockReddy on Jan 09, 2020 10:46pm

Boehringer Ingelheim & Enleofen Ink $1 Billion+Fibrosis Deal

One day LMNL will be....

118

Comment

Comment by StockReddy on Jan 09, 2020 11:06pm

here is the link https://www.biospace.com/article/boehringer-ingelheim-partners-with-enleofen-for-fibrotic-diseases/

Comment

Comment by GunnerG on Jan 10, 2020 10:33am

This is the second or turd NR posted by pumpers that a major pharm has spent $1 Billion+ on a Fibrosis Deal. Not sure how you think this is a positive for this company. Its like picking teams at grade school and LMNL is that last kid to be picked, LOL. You have to wonder why the others are getting bought out and PLI / LMNL can't get it done. Pierre tried for years, the "new ...more

Comment